| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.91B | 66.98B | 60.60B | 59.74B | 46.78B | 36.93B |
| Gross Profit | 46.91B | 49.86B | 43.84B | 43.09B | 38.18B | 35.45B |
| EBITDA | 5.99B | 12.12B | 9.41B | 8.76B | 9.99B | 10.48B |
| Net Income | 5.80B | 7.21B | 5.71B | 5.05B | 5.39B | 5.78B |
Balance Sheet | ||||||
| Total Assets | 2.84T | 3.08T | 2.96T | 2.89T | 2.89T | 2.89T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 346.76B | 269.08B | 204.90B | 218.00B | 339.77B |
| Total Debt | 66.57B | 120.22B | 71.00B | 72.74B | 95.58B | 128.39B |
| Total Liabilities | 2.71T | 2.94T | 2.83T | 2.75T | 2.76T | 2.75T |
| Stockholders Equity | 138.57B | 144.14B | 135.45B | 137.16B | 127.54B | 134.69B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.06B | 0.00 | -15.28B | -76.84B | 82.33B |
| Operating Cash Flow | 0.00 | 9.16B | 0.00 | -24.97B | -74.62B | 84.61B |
| Investing Cash Flow | 0.00 | -37.05B | 20.82B | 13.02B | -45.95B | -24.34B |
| Financing Cash Flow | 0.00 | 103.85B | 55.73B | -1.29B | -1.17B | -7.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥77.99B | 8.35 | ― | 2.34% | 3.68% | 26.06% | |
71 Outperform | ¥115.26B | 5.37 | ― | 3.05% | 49.84% | 156.03% | |
71 Outperform | ¥268.73B | 14.34 | ― | 2.53% | 16.63% | 19.98% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥959.67B | 11.15 | ― | 2.10% | 8.96% | 42.70% | |
65 Neutral | ¥174.91B | 10.12 | ― | 2.29% | 9.41% | 45.91% | |
60 Neutral | ¥13.13B | 17.45 | ― | 2.74% | 17.43% | -35.15% |